Public Company News

Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First COVID-19 Neutralizing Antibody Combination Therapy in China

The approval marks the first locally-discovered and approved SARS-CoV-2 target-specific treatment inChina, through a randomized, double-blind and placebo-controlled trial Brii Bio is also seeking U.S. FDA Emergency Use Authorization for the amubarvimab/romlusevimab combination DURHAM, N.C. and ...

2021-12-09 06:10 4514

Okada Manila International, Inc. and 26 Capital Acquisition Corp. (NASDAQ: ADER) Announce Plans to Participate in the New York State Gaming Commission's Request for Information Regarding Casino Licenses

MANILA, MIAMI, and TOKYO, Dec. 9, 2021 /PRNewswire/ -- Okada Manila International, Inc., a subsidiary of Universal Entertainment Corporation (TSE: 6425) and an affiliate of the operator of Okada Manila, and 26 Capital Acquisition Corp. today announced that they will submit plans in response to th...

2021-12-09 01:04 3964

Okada Manila International, Inc. Announces Corporate Name Change to UE Resorts International, Inc.

The name change underscores the corporation's commitment and focus on driving growth opportunities and providing guests with a first-class experience MANILA, Philippines and TOKYO, Dec. 8, 2021 /PRNewswire/ -- Okada Manila International, Inc., the anticipated holding company of Okada Manila, one ...

2021-12-09 00:49 5284

Secureworks Applauded by Frost & Sullivan for Driving the Evolution of Managed and Professional Security Services Market with Taegis ManagedXDR

Secureworks Taegis XDR, a Cloud-Native Solution propels Secureworks into the next generation of security services focused on detection and response SAN ANTONIO, Dec. 8, 2021 /PRNewswire/ -- Frost & Sullivan recently assessed the North American managed and professional security services market and...

2021-12-08 22:05 4100

Secureworks Wins Frost & Sullivan's 2021 Company of the Year Award for Taegis ManagedXDR Innovation in the North American Managed and Professional Security Services Market

Honor highlights Secureworks Taegis Cloud-Native XDR leadership and customer impact ATLANTA, Dec. 8, 2021 /PRNewswire/ -- Secureworks® (NASDAQ: SCWX), a global leader in cybersecurity, today was named Frost & Sullivan's 2021 Best Practices Company of the Year for driving the evolution of the Man...

2021-12-08 22:00 2987

Olay celebrates fearless healthcare frontliners with USD $1.9 million donation as part of a new campaign

SINGAPORE, Dec. 8, 2021 /PRNewswire/ -- Skincare brand, Olay, announced today the launch of a new appreciation campaign for healthcare workers inSingapore as they continue in the battle against COVID-19. As part of the campaign, it has donated USD$1.9 million worth of Olay products to healthcare ...

2021-12-08 19:35 4237

JinkoSolar Signed an 50MW Solar Modules Distribution Agreement with Zonergy Solar Development Pakistan LTD. for 2021 in Pakistan

SHANGHAI, Dec. 8, 2021 /PRNewswire/ -- On 2nd of December, Jinko Solar Holding Co. Ltd., (JinkoSolar) - a world-leading quality solar panel manufacturer with Zonergy Solar Development Pakistan LTD - one of the major distributors., reputation of solar energy development company inPakistan market h...

2021-12-08 18:11 3548

Clarivate and the Chinese Academy of Sciences Release Annual Joint Report to Identify 171 Research Fronts

Selecting 110 hot and 61 emerging research specialties in 11 areas of sciences and socialsciences LONDON, Dec. 8, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, and theChinese Academy of Science...

2021-12-08 18:05 3536

JinkoSolar Signed a 360MW Module Supply Agreement Focusing On Tiger Neo with Tadiran Solar in Israel

SHANGHAI, Dec. 8, 2021 /PRNewswire/ -- JinkoSolar Holding Co. Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it has signed a 360MW solar modules supply agreement with Tadiran Solar Ltd. - one o...

2021-12-08 16:55 3518

BloombergNEF Summit: Trina Solar's 100% bankability and Vertex modules fully proved by international authorities

SHANGHAI, Dec. 8, 2021 /PRNewswire/ -- On November 30, 2021, Bloomberg New Energy Finance (BloombergNEF) held the 2021 BloombergNEF Shanghai Summit. Trina Solar Chairman Gao Jifan discussed innovations in energy technologies and the development path for the PV industry with international organiza...

2021-12-08 15:15 4904

LTI Launches Fosfor, the Data-to-Decisions Product Suite for Monetizing Data

MUMBAI, India, Dec. 8, 2021 /PRNewswire/ -- Larsen & Toubro Infotech (BSE: 540005) (NSE: LTI), a global technology consulting and digital solutions company, today launchedFosfor , the Data-to-Decisions Product Suite. Fosfor helps businesses ...

2021-12-08 14:40 4825

Lam Research Unveils Syndion GP to Help Chipmakers Meet Demand for Advanced Power Devices

SINGAPORE and FREMONT, Calif., Dec. 8, 2021 /PRNewswire/ -- Lam Research Corp. (NASDAQ: LRCX) today announced Syndion® GP: a new product that provides deep silicon etch capabilities to chipmakers developing next generation power devices and power management integrated circuits used in the auto...

2021-12-08 10:00 5310

Black Desert Mobile Celebrates 2nd Anniversary with Exciting Events and Rewards

SEOUL, South Korea, Dec. 8, 2021 /PRNewswire/ -- Pearl Abyss today announced the 2nd anniversary ofBlack Desert Mobile and an array of exciting events to celebrate the milestone.  Black Desert Mobile Celebrates 2nd Anniversary with Exciting E...

2021-12-08 10:00 3638

GWM Launches HAVAL DARGO globally at the Jeddah Motor Show

BAODING, China, Dec. 8, 2021 /PRNewswire/ -- On December 6, the new GWM model HAVAL DARGO was unveiled at the Jeddah Motor Show in Saudi Arabia and its global name was announced worldwide for the first time. The Jeddah Motor Show is one of the largest motor shows in the Middle East market and it...

2021-12-08 09:00 8231

Henlius' Phase 3 clinical study of novel PD-1 inhibitor serplulimab for the treatment of first-line extensive-stage small cell lung cancer (ES-SCLC) meets primary study endpoint

SHANGHAI, Dec. 8, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the first interim analysis met the primary study endpoint of the overall survival (OS) of the Phase 3 clinical study (NCT04063163) of its innovative PD-1 inhibitor serplulimab in combination with chemot...

2021-12-08 08:30 4291

Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement

HANGZHOU, China, Dec. 8, 2021 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its acquisition of Cardiovalve Ltd. (Cardiovalve), a pioneering transcatheter mitral and tricuspid valve treatm...

2021-12-08 08:28 5068

ACLEDA Bank Chooses Diebold Nixdorf to Enhance Self-Service Banking Experience

NORTH CANTON, Ohio and PHNOM PENH, Cambodia, Dec. 8, 2021 /PRNewswire/ -- Diebold Nixdorf (NYSE: DBD), a global leader in driving connected commerce for the financial and retail industries, announced today that ACLEDA Bank Plc., a leading retail bank based inCambodia, has selected its comprehensi...

2021-12-08 08:00 6023

Ping An's AI-driven AskBob Doctor Earns Top Scores in Diabetes Management Competition

HONG KONG and SHANGHAI, Dec. 8, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that its AskBob Doctor, an artificial intelligence-driven consultation and treatment assistance tool, scored an average of 92....

2021-12-08 05:44 5140

CP-COV03, a niclosamide-based oral antiviral drug, under study as possible cure for COVID-19 variants

SUMMARY CP-COV03, a niclosamide-based oral antiviral drug, to cure COVID-19 variants CP-COV03 is a broad-spectrum antiviral drug candidate, developed by Hyundai Bioscience to treat COVID-19. Its active pharmaceutical ingredient is niclosamide, an anthelmintic drug, and is expected to work on var...

2021-12-07 22:00 3361

Global Cord Blood Corporation Announces Results of 2021 Annual General Meeting

HONG KONG, Dec. 7, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2021 Annual Gene...

2021-12-07 21:35 3422
1 ... 868869870871872873874 ... 904